Copyright Reports & Markets. All rights reserved.

Global HIV and AIDS Diagnostics Market 2026 by Company, Regions, Type and Application, Forecast to 2032

Request for Sample of this report
Buy now

1 Market Overview

  • 1.1 Product Overview and Scope
  • 1.2 Market Estimation Caveats and Base Year
  • 1.3 Classification of HIV and AIDS Diagnostics by Type
    • 1.3.1 Overview: Global HIV and AIDS Diagnostics Market Size by Type: 2021 Versus 2025 Versus 2032
    • 1.3.2 Global HIV and AIDS Diagnostics Consumption Value Market Share by Type in 2025
    • 1.3.3 Reagent Test Kit
    • 1.3.4 Instrument
    • 1.3.5 Others
  • 1.4 Global HIV and AIDS Diagnostics Market by Application
    • 1.4.1 Overview: Global HIV and AIDS Diagnostics Market Size by Application: 2021 Versus 2025 Versus 2032
    • 1.4.2 Hospitals
    • 1.4.3 Private Diagnostic Laboratories
    • 1.4.4 Academic and Research Institutes
  • 1.5 Global HIV and AIDS Diagnostics Market Size & Forecast
  • 1.6 Global HIV and AIDS Diagnostics Market Size and Forecast by Region
    • 1.6.1 Global HIV and AIDS Diagnostics Market Size by Region: 2021 VS 2025 VS 2032
    • 1.6.2 Global HIV and AIDS Diagnostics Market Size by Region, (2021-2032)
    • 1.6.3 North America HIV and AIDS Diagnostics Market Size and Prospect (2021-2032)
    • 1.6.4 Europe HIV and AIDS Diagnostics Market Size and Prospect (2021-2032)
    • 1.6.5 Asia-Pacific HIV and AIDS Diagnostics Market Size and Prospect (2021-2032)
    • 1.6.6 South America HIV and AIDS Diagnostics Market Size and Prospect (2021-2032)
    • 1.6.7 Middle East & Africa HIV and AIDS Diagnostics Market Size and Prospect (2021-2032)

2 Company Profiles

  • 2.1 Siemens Healthineers
    • 2.1.1 Siemens Healthineers Details
    • 2.1.2 Siemens Healthineers Major Business
    • 2.1.3 Siemens Healthineers HIV and AIDS Diagnostics Product and Solutions
    • 2.1.4 Siemens Healthineers HIV and AIDS Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.1.5 Siemens Healthineers Recent Developments and Future Plans
  • 2.2 Bio-Rad
    • 2.2.1 Bio-Rad Details
    • 2.2.2 Bio-Rad Major Business
    • 2.2.3 Bio-Rad HIV and AIDS Diagnostics Product and Solutions
    • 2.2.4 Bio-Rad HIV and AIDS Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.2.5 Bio-Rad Recent Developments and Future Plans
  • 2.3 Abbott Laboratories
    • 2.3.1 Abbott Laboratories Details
    • 2.3.2 Abbott Laboratories Major Business
    • 2.3.3 Abbott Laboratories HIV and AIDS Diagnostics Product and Solutions
    • 2.3.4 Abbott Laboratories HIV and AIDS Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.3.5 Abbott Laboratories Recent Developments and Future Plans
  • 2.4 OraSure TechnologieS
    • 2.4.1 OraSure TechnologieS Details
    • 2.4.2 OraSure TechnologieS Major Business
    • 2.4.3 OraSure TechnologieS HIV and AIDS Diagnostics Product and Solutions
    • 2.4.4 OraSure TechnologieS HIV and AIDS Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.4.5 OraSure TechnologieS Recent Developments and Future Plans
  • 2.5 F. Hoffmann-La Roche
    • 2.5.1 F. Hoffmann-La Roche Details
    • 2.5.2 F. Hoffmann-La Roche Major Business
    • 2.5.3 F. Hoffmann-La Roche HIV and AIDS Diagnostics Product and Solutions
    • 2.5.4 F. Hoffmann-La Roche HIV and AIDS Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.5.5 F. Hoffmann-La Roche Recent Developments and Future Plans
  • 2.6 Hologic
    • 2.6.1 Hologic Details
    • 2.6.2 Hologic Major Business
    • 2.6.3 Hologic HIV and AIDS Diagnostics Product and Solutions
    • 2.6.4 Hologic HIV and AIDS Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.6.5 Hologic Recent Developments and Future Plans
  • 2.7 Abbott
    • 2.7.1 Abbott Details
    • 2.7.2 Abbott Major Business
    • 2.7.3 Abbott HIV and AIDS Diagnostics Product and Solutions
    • 2.7.4 Abbott HIV and AIDS Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.7.5 Abbott Recent Developments and Future Plans
  • 2.8 Chembio Diagnostic Systems
    • 2.8.1 Chembio Diagnostic Systems Details
    • 2.8.2 Chembio Diagnostic Systems Major Business
    • 2.8.3 Chembio Diagnostic Systems HIV and AIDS Diagnostics Product and Solutions
    • 2.8.4 Chembio Diagnostic Systems HIV and AIDS Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.8.5 Chembio Diagnostic Systems Recent Developments and Future Plans
  • 2.9 BD
    • 2.9.1 BD Details
    • 2.9.2 BD Major Business
    • 2.9.3 BD HIV and AIDS Diagnostics Product and Solutions
    • 2.9.4 BD HIV and AIDS Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.9.5 BD Recent Developments and Future Plans
  • 2.10 Danaher Corporation
    • 2.10.1 Danaher Corporation Details
    • 2.10.2 Danaher Corporation Major Business
    • 2.10.3 Danaher Corporation HIV and AIDS Diagnostics Product and Solutions
    • 2.10.4 Danaher Corporation HIV and AIDS Diagnostics Revenue, Gross Margin and Market Share (2021-2026)
    • 2.10.5 Danaher Corporation Recent Developments and Future Plans

3 Market Competition, by Players

  • 3.1 Global HIV and AIDS Diagnostics Revenue and Share by Players (2021-2026)
  • 3.2 Market Share Analysis (2025)
    • 3.2.1 Market Share of HIV and AIDS Diagnostics by Company Revenue
    • 3.2.2 Top 3 HIV and AIDS Diagnostics Players Market Share in 2025
    • 3.2.3 Top 6 HIV and AIDS Diagnostics Players Market Share in 2025
  • 3.3 HIV and AIDS Diagnostics Market: Overall Company Footprint Analysis
    • 3.3.1 HIV and AIDS Diagnostics Market: Region Footprint
    • 3.3.2 HIV and AIDS Diagnostics Market: Company Product Type Footprint
    • 3.3.3 HIV and AIDS Diagnostics Market: Company Product Application Footprint
  • 3.4 New Market Entrants and Barriers to Market Entry
  • 3.5 Mergers, Acquisition, Agreements, and Collaborations

4 Market Size Segment by Type

  • 4.1 Global HIV and AIDS Diagnostics Consumption Value and Market Share by Type (2021-2026)
  • 4.2 Global HIV and AIDS Diagnostics Market Forecast by Type (2027-2032)

5 Market Size Segment by Application

  • 5.1 Global HIV and AIDS Diagnostics Consumption Value Market Share by Application (2021-2026)
  • 5.2 Global HIV and AIDS Diagnostics Market Forecast by Application (2027-2032)

6 North America

  • 6.1 North America HIV and AIDS Diagnostics Consumption Value by Type (2021-2032)
  • 6.2 North America HIV and AIDS Diagnostics Market Size by Application (2021-2032)
  • 6.3 North America HIV and AIDS Diagnostics Market Size by Country
    • 6.3.1 North America HIV and AIDS Diagnostics Consumption Value by Country (2021-2032)
    • 6.3.2 United States HIV and AIDS Diagnostics Market Size and Forecast (2021-2032)
    • 6.3.3 Canada HIV and AIDS Diagnostics Market Size and Forecast (2021-2032)
    • 6.3.4 Mexico HIV and AIDS Diagnostics Market Size and Forecast (2021-2032)

7 Europe

  • 7.1 Europe HIV and AIDS Diagnostics Consumption Value by Type (2021-2032)
  • 7.2 Europe HIV and AIDS Diagnostics Consumption Value by Application (2021-2032)
  • 7.3 Europe HIV and AIDS Diagnostics Market Size by Country
    • 7.3.1 Europe HIV and AIDS Diagnostics Consumption Value by Country (2021-2032)
    • 7.3.2 Germany HIV and AIDS Diagnostics Market Size and Forecast (2021-2032)
    • 7.3.3 France HIV and AIDS Diagnostics Market Size and Forecast (2021-2032)
    • 7.3.4 United Kingdom HIV and AIDS Diagnostics Market Size and Forecast (2021-2032)
    • 7.3.5 Russia HIV and AIDS Diagnostics Market Size and Forecast (2021-2032)
    • 7.3.6 Italy HIV and AIDS Diagnostics Market Size and Forecast (2021-2032)

8 Asia-Pacific

  • 8.1 Asia-Pacific HIV and AIDS Diagnostics Consumption Value by Type (2021-2032)
  • 8.2 Asia-Pacific HIV and AIDS Diagnostics Consumption Value by Application (2021-2032)
  • 8.3 Asia-Pacific HIV and AIDS Diagnostics Market Size by Region
    • 8.3.1 Asia-Pacific HIV and AIDS Diagnostics Consumption Value by Region (2021-2032)
    • 8.3.2 China HIV and AIDS Diagnostics Market Size and Forecast (2021-2032)
    • 8.3.3 Japan HIV and AIDS Diagnostics Market Size and Forecast (2021-2032)
    • 8.3.4 South Korea HIV and AIDS Diagnostics Market Size and Forecast (2021-2032)
    • 8.3.5 India HIV and AIDS Diagnostics Market Size and Forecast (2021-2032)
    • 8.3.6 Southeast Asia HIV and AIDS Diagnostics Market Size and Forecast (2021-2032)
    • 8.3.7 Australia HIV and AIDS Diagnostics Market Size and Forecast (2021-2032)

9 South America

  • 9.1 South America HIV and AIDS Diagnostics Consumption Value by Type (2021-2032)
  • 9.2 South America HIV and AIDS Diagnostics Consumption Value by Application (2021-2032)
  • 9.3 South America HIV and AIDS Diagnostics Market Size by Country
    • 9.3.1 South America HIV and AIDS Diagnostics Consumption Value by Country (2021-2032)
    • 9.3.2 Brazil HIV and AIDS Diagnostics Market Size and Forecast (2021-2032)
    • 9.3.3 Argentina HIV and AIDS Diagnostics Market Size and Forecast (2021-2032)

10 Middle East & Africa

  • 10.1 Middle East & Africa HIV and AIDS Diagnostics Consumption Value by Type (2021-2032)
  • 10.2 Middle East & Africa HIV and AIDS Diagnostics Consumption Value by Application (2021-2032)
  • 10.3 Middle East & Africa HIV and AIDS Diagnostics Market Size by Country
    • 10.3.1 Middle East & Africa HIV and AIDS Diagnostics Consumption Value by Country (2021-2032)
    • 10.3.2 Turkey HIV and AIDS Diagnostics Market Size and Forecast (2021-2032)
    • 10.3.3 Saudi Arabia HIV and AIDS Diagnostics Market Size and Forecast (2021-2032)
    • 10.3.4 UAE HIV and AIDS Diagnostics Market Size and Forecast (2021-2032)

11 Market Dynamics

  • 11.1 HIV and AIDS Diagnostics Market Drivers
  • 11.2 HIV and AIDS Diagnostics Market Restraints
  • 11.3 HIV and AIDS Diagnostics Trends Analysis
  • 11.4 Porters Five Forces Analysis
    • 11.4.1 Threat of New Entrants
    • 11.4.2 Bargaining Power of Suppliers
    • 11.4.3 Bargaining Power of Buyers
    • 11.4.4 Threat of Substitutes
    • 11.4.5 Competitive Rivalry

12 Industry Chain Analysis

  • 12.1 HIV and AIDS Diagnostics Industry Chain
  • 12.2 HIV and AIDS Diagnostics Upstream Analysis
  • 12.3 HIV and AIDS Diagnostics Midstream Analysis
  • 12.4 HIV and AIDS Diagnostics Downstream Analysis

13 Research Findings and Conclusion

    14 Appendix

    • 14.1 Methodology
    • 14.2 Research Process and Data Source

    According to our (Global Info Research) latest study, the global HIV and AIDS Diagnostics market size was valued at US$ 3186 million in 2025 and is forecast to a readjusted size of US$ 4431 million by 2032 with a CAGR of 4.9% during review period.
    This report is a detailed and comprehensive analysis for global HIV and AIDS Diagnostics market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
    Key Features:
    Global HIV and AIDS Diagnostics market size and forecasts, in consumption value ($ Million), 2021-2032
    Global HIV and AIDS Diagnostics market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
    Global HIV and AIDS Diagnostics market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
    Global HIV and AIDS Diagnostics market shares of main players, in revenue ($ Million), 2021-2026
    The Primary Objectives in This Report Are:
    To determine the size of the total market opportunity of global and key countries
    To assess the growth potential for HIV and AIDS Diagnostics
    To forecast future growth in each product and end-use market
    To assess competitive factors affecting the marketplace
    This report profiles key players in the global HIV and AIDS Diagnostics market based on the following parameters - company overview, revenue, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Siemens Healthineers, Bio-Rad, Abbott Laboratories, OraSure TechnologieS, F. Hoffmann-La Roche, Hologic, Abbott, Chembio Diagnostic Systems, BD, Danaher Corporation, etc.
    This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
    Market segmentation
    HIV and AIDS Diagnostics market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
    Market segment by Type
    Reagent Test Kit
    Instrument
    Others
    Market segment by Application
    Hospitals
    Private Diagnostic Laboratories
    Academic and Research Institutes
    Market segment by players, this report covers
    Siemens Healthineers
    Bio-Rad
    Abbott Laboratories
    OraSure TechnologieS
    F. Hoffmann-La Roche
    Hologic
    Abbott
    Chembio Diagnostic Systems
    BD
    Danaher Corporation
    Market segment by regions, regional analysis covers
    North America (United States, Canada and Mexico)
    Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
    Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
    South America (Brazil, Rest of South America)
    Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
    The content of the study subjects, includes a total of 13 chapters:
    Chapter 1, to describe HIV and AIDS Diagnostics product scope, market overview, market estimation caveats and base year.
    Chapter 2, to profile the top players of HIV and AIDS Diagnostics, with revenue, gross margin, and global market share of HIV and AIDS Diagnostics from 2021 to 2026.
    Chapter 3, the HIV and AIDS Diagnostics competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
    Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
    Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and HIV and AIDS Diagnostics market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
    Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
    Chapter 12, the key raw materials and key suppliers, and industry chain of HIV and AIDS Diagnostics.
    Chapter 13, to describe HIV and AIDS Diagnostics research findings and conclusion.

    Buy now